Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression. 2019

Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
Department of Obstetrics and Gynaecology, The Affiliated Hospital of Qingdao University, Qingdao, China.

As shown in our previous studies, growth and metastasis of ovarian cancer can be regulated by adipose-derived mesenchymal stem cells (ADSCs). However, the underlying mechanism has not yet been revealed. In this study, a proteomics analysis was performed to compare protein expression treated with and without ADSCs in ovarian cancer cells. Protein levels were altered in ovarian cancer cells due to the treatment of ADSCs. Thymosin beta 4 X-linked (TMSB4X) levels changed dramatically, and this protein was identified as one of the most important candidate molecules contributing to the tumour-promoting effects of ADSCs. Compared with the cells that are cultured in the normal growth medium, the TMSB4X levels cultured in ADSC-conditioned medium increased significantly in ovarian cancer cells. Furthermore, the growth and invasion of cancer cells were decreased, even in the ADSC-conditioned medium treatment group (P < 0.05), by the inhibition of TMSB4X. As shown in the bioluminescence images captured in vivo, increased ovarian cancer's growth and metastasis, along with elevated TMSB4X expression, were observed in the group of ADSC-conditioned medium, and the tumour-promoting effect of ADSCs was attenuated by the inhibition of TMSB4X. Based on our findings, increased TMSB4X expression may play a role in accelerating the ADSC-mediated proliferation, invasion, and migration of ovarian cancers.

UI MeSH Term Description Entries

Related Publications

Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
January 2020, Frontiers in cell and developmental biology,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
November 2010, International journal of cancer,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
May 2021, Journal of cellular and molecular medicine,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
August 2021, Experimental biology and medicine (Maywood, N.J.),
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
January 2021, Frontiers in oncology,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
December 2017, Molecular medicine reports,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
January 2020, Advances in experimental medicine and biology,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
January 2022, Cell transplantation,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
September 2015, Experimental cell research,
Yijing Chu, and Min You, and Jingjing Zhang, and Guoqiang Gao, and Rendong Han, and Wenqiang Luo, and Tingting Liu, and Jianxin Zuo, and Fuling Wang
May 2020, Cellular signalling,
Copied contents to your clipboard!